Synagis

Synagis Caution For Usage

palivizumab

Manufacturer:

AstraZeneca

Distributor:

Zuellig
Full Prescribing Info
Caution For Usage
Special Precautions for Disposal and Other Handling: Do not mix the palivizumab liquid and lyophilised formulations.
Do not dilute the product.
Do not shake the vial.
Synagis 50mg/0.5mL: 0.5 mL vials contain an overfill to allow the withdrawal of 50 mg.
Synagis 100mg/1mL:
1 mL vials contain an overfill to allow the withdrawal of 100 mg.
To administer, remove the tab portion of the vial cap and clean the stopper with 70% ethanol or equivalent. Insert the needle into the vial and withdraw into the syringe an appropriate volume of solution.
Palivizumab solution for injection does not contain a preservative, is for single use and should be administered immediately after drawing the dose into the syringe.
Any unused product or waste material should be disposed of in accordance with local requirements.
Incompatibilities: This medicinal product should not be mixed with other medicinal products.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in